| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Ticho Barry is a Chief Medical Officer at STOK. Recent filings cover 0 purchases and 60 sales. Those positions are worth an estimated $668K at current prices.
Our model assigns Ticho Barry a middling insider score of 50/100, based on 43 past trades. Over a 12-month horizon, 34.4% of those trades were profitable, with an average 12-month return of -29.4%.
Ticho Barry's largest disclosed position is in STOK as Chief Medical Officer, worth about $668K. The recent filings there lean toward selling, a net 378,174 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 26,631 | $10.02 | $266,952.68 | -22.7% | +33.4% | - | |
| Mar 19, 2025 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 7,217 | $8.49 | $61,238.19 | -5.5% | +41.2% | +301.8% | |
| Dec 9, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 2,586 | $12.99 | $33,595.50 | -5.5% | -42.2% | +121.4% | |
| Dec 6, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 13,945 | $12.78 | $178,182.24 | -22.8% | -38.6% | +132.6% | |
| Dec 2, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $12.07 | $120,698.00 | -16.3% | -38.7% | +147.0% | |
| Nov 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $12.68 | $126,803.00 | -80.1% | -14.5% | +133.6% | |
| Oct 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $12.06 | $120,648.00 | -80.1% | -12.7% | +90.7% | |
| Sep 3, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $14.95 | $149,480.76 | -64.2% | -19.7% | +31.5% | |
| Aug 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $14.58 | $145,843.00 | -80.1% | -15.1% | -12.3% | |
| Jul 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $13.75 | $137,458.00 | -80.1% | -11.4% | -16.0% |